Logo image of ECX

ECARX HOLDINGS INC-CL A (ECX) Stock Fundamental Analysis

NASDAQ:ECX - Nasdaq - KYG292011031 - Common Stock - Currency: USD

2.04  +0.09 (+4.62%)

After market: 2.15 +0.11 (+5.39%)

Fundamental Rating

2

Taking everything into account, ECX scores 2 out of 10 in our fundamental rating. ECX was compared to 83 industry peers in the Automobile Components industry. Both the profitability and financial health of ECX have multiple concerns. While showing a medium growth rate, ECX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ECX has reported negative net income.
In the past year ECX has reported a negative cash flow from operations.
ECX Yearly Net Income VS EBIT VS OCF VS FCFECX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -500M -1B -1.5B

1.2 Ratios

ECX has a worse Return On Assets (-22.03%) than 90.36% of its industry peers.
Industry RankSector Rank
ROA -22.03%
ROE N/A
ROIC N/A
ROA(3y)-32.66%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ECX Yearly ROA, ROE, ROICECX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 200 -200 400 600 800

1.3 Margins

ECX has a Gross Margin of 27.22%. This is in the lower half of the industry: ECX underperforms 62.65% of its industry peers.
ECX's Gross Margin has improved in the last couple of years.
ECX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.42%
GM growth 5YN/A
ECX Yearly Profit, Operating, Gross MarginsECX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

ECX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, ECX has a worse debt to assets ratio.
ECX Yearly Shares OutstandingECX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M
ECX Yearly Total Debt VS Total AssetsECX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of -1.51, we must say that ECX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ECX (-1.51) is worse than 86.75% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.51
ROIC/WACCN/A
WACC7.67%
ECX Yearly LT Debt VS Equity VS FCFECX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M -500M -1B -1.5B

2.3 Liquidity

ECX has a Current Ratio of 0.78. This is a bad value and indicates that ECX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.78, ECX is doing worse than 96.39% of the companies in the same industry.
A Quick Ratio of 0.74 indicates that ECX may have some problems paying its short term obligations.
With a Quick ratio value of 0.74, ECX is not doing good in the industry: 90.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.74
ECX Yearly Current Assets VS Current LiabilitesECX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B 4B

More info and screens

6

3. Growth

3.1 Past

ECX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.42%, which is quite impressive.
The Revenue has grown by 31.18% in the past year. This is a very strong growth!
ECX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.69% yearly.
EPS 1Y (TTM)50.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-811.9%
Revenue 1Y (TTM)31.18%
Revenue growth 3Y27.69%
Revenue growth 5YN/A
Sales Q2Q%883.24%

3.2 Future

Based on estimates for the next years, ECX will show a very strong growth in Earnings Per Share. The EPS will grow by 45.93% on average per year.
Based on estimates for the next years, ECX will show a quite strong growth in Revenue. The Revenue will grow by 18.50% on average per year.
EPS Next Y-636.49%
EPS Next 2Y-76.5%
EPS Next 3Y45.93%
EPS Next 5YN/A
Revenue Next Year22.14%
Revenue Next 2Y27.31%
Revenue Next 3Y27.78%
Revenue Next 5Y18.5%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECX Yearly Revenue VS EstimatesECX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
ECX Yearly EPS VS EstimatesECX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ECX. In the last year negative earnings were reported.
Also next year ECX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECX Price Earnings VS Forward Price EarningsECX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECX Per share dataECX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ECX's earnings are expected to grow with 45.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.5%
EPS Next 3Y45.93%

More info and screens

0

5. Dividend

5.1 Amount

ECX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECARX HOLDINGS INC-CL A

NASDAQ:ECX (2/21/2025, 8:15:03 PM)

After market: 2.15 +0.11 (+5.39%)

2.04

+0.09 (+4.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-11 2025-03-11/bmo
Inst Owners3.56%
Inst Owner Change12.54%
Ins Owners0.03%
Ins Owner Change0%
Market Cap689.42M
Analysts82.5
Price Target3.71 (81.86%)
Short Float %0.46%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.2%
Min EPS beat(2)-21.01%
Max EPS beat(2)8.61%
EPS beat(4)3
Avg EPS beat(4)17%
Min EPS beat(4)-21.01%
Max EPS beat(4)43.42%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)7.86%
Min Revenue beat(2)-8.62%
Max Revenue beat(2)24.34%
Revenue beat(4)1
Avg Revenue beat(4)3.44%
Min Revenue beat(4)-8.62%
Max Revenue beat(4)24.34%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-619.77%
EPS NQ rev (3m)-619.77%
EPS NY rev (1m)-13.64%
EPS NY rev (3m)-746.69%
Revenue NQ rev (1m)619.79%
Revenue NQ rev (3m)619.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)663.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS1.9
BVpS-0.38
TBVpS-0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.22%
FCFM N/A
ROA(3y)-32.66%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.42%
GM growth 5YN/A
F-Score3
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.49%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.74
Altman-Z -1.51
F-Score3
WACC7.67%
ROIC/WACCN/A
Cap/Depr(3y)127.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-811.9%
EPS Next Y-636.49%
EPS Next 2Y-76.5%
EPS Next 3Y45.93%
EPS Next 5YN/A
Revenue 1Y (TTM)31.18%
Revenue growth 3Y27.69%
Revenue growth 5YN/A
Sales Q2Q%883.24%
Revenue Next Year22.14%
Revenue Next 2Y27.31%
Revenue Next 3Y27.78%
Revenue Next 5Y18.5%
EBIT growth 1Y55.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.73%
EBIT Next 3Y32.31%
EBIT Next 5Y23.23%
FCF growth 1Y-144.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-206.41%
OCF growth 3YN/A
OCF growth 5YN/A